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Abstract. Macrophages that have ingested live Mycobacterium leprae show a preferential
accumulation of cholesterol ester. Such an accumulation is not seen, on the ingestion of dead 
bacteria. Among the macrophages that ingest live Mycobacterium leprae, the presence of 
dapsone or rifampicin prevents largely the alteration in the anticipated increase in the 
cholesterol ester indicating the sensitivity of the bacteria to the drug. In the small number of 
relapsed patients, the presence of dapsone did not reduce the cholesterol ester increase, 
suggesting that the Mycobacterium leprae present are either resistant or escaped detection. The 
method provides a rapid drug screening system for anti-Mycobacterium leprae activity of
known and unknown compounds. 
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Introduction
 
The screening of antimicrobials for anti leprosy activity has not been extensively
undertaken. The mouse foot-pad growth technique with Mycobacterium leprae is 
claimed to be a well defined and reliable technique to test the viability and growth of M. 
leprae (Shepard, 1960). The same technique can be used to find out whether the M. 
leprae are susceptible to a drug or not by determining the growth in the foot-pad of 
mice, fed on a diet containing the drug (Shepard, 1967). This method has been refined 
and made more sensitive using thymectomised mice (Rees, 1966) or genetically bred 
nude mice (nu/nu) (Kohsaka et al., 1978). However all these test systems need a 
minimum of 6-8 months even before preliminary assessment could be made. In view of 
this there is an urgent need for a rapid test system to determine drug sensitivity/resist- 
ance of M. leprae. The major limitation that has to be overcome with M. leprae is our 
inability to grow it in vitro, on any of the currently available bacteriological media in a 
reasonably short time. 
We describe here a method for testing viability that could also be used for drug
sensitivity testing of M. leprae, when the bacteria are resident in macrophages. The 
basic reaction monitored in this test system, is the influence that only live M. leprae 
exert on the cholesterol metabolism of the macrophages (Ishwari Kurup and 
 
 
Abbreviations used: DDS, Dapsone (di-(4-aminophenyl)-sulphone; DOPA, dihydroxyphenylalanine. 
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Mahadevan, 1982) leading to the formation of cholesterol ester from cholesterol taken
up, as compared with macrophages with no live M. leprae inside. The present paper 
describes the adaptation of this observation for the development of a suitable and rapid 
drug sensitivity test that can even be used in an anti-leprosy drug screening programme. 
 
 
Materials and methods 
 
Mycobacterium leprae were obtained from lepromatous tissue of bacillary positive, 
untreated patients or those under varying periods of chemotherapy. Bacillary 
suspensions were prepared (Ambrose et al., 1974) and shown to be acid-fast and free 
from other contaminating bacteria. These fail to grow in normal mycobacteriological 
media. The bacilli were counted and 5 × 106 bacilli were added to each Leighton tube 
containing cultured macrophages. M. leprae obtained from infected armadillo tissue 
(supplied by Dr. E. Storrs, Florida, USA) were also used in some of the experiments. 
 
Macrophage cultures 
 
Macrophages from Swiss white mice were obtained from the peritoneal cavity 
following injection of 5 ml Eagle’s minimal essential medium +20% inactivated 
human serum (AB blood group) into the cavity, after killing the animal by cervical 
dislocation immediately after the injection of the medium. The peritoneal fluid was 
collected after agitating the cavity, and 0·7 ml of the fluid was added to each Leighton 
tube. The macrophages obtained from the peritoneal fluid adhered to the Leighton 
tubes. The medium was changed every 24 h; to remove non adherent cells. After 3 days 
of such culturing, esterase positive phagocytic cells, were predominantly distributed as 
an uniform layer at the flat bottom of Leighton tubes. There were no contaminating 
neutrophils, and non-adherent lymphocytes were not present in any significant 
numbers. Such tubes were divided into 5 sets. One set received viable M. leprae 
(5 × 106/Leighton tube) either from human biopsies or armadillo and another heat- 
killed M. leprae (5 × 106/Leighton tube). The control sets did not receive the M. leprae 
inoculum. The level of M. leprae to be added had earlier been confirmed as a good dose 
to elicit clear response from the macrophages (Ishwari Kurup and Mahadevan 1982). 
After 24 h of phagocytosis of the bacteria, the excess bacilli were removed and the 
macrophages were incubated with [3H]-cholesterol. The experiments were also carried 
using [14C]-acetate as precursor. Some of the cultured macrophages were exposed to 
drugs like dapsone (di(4-aminophenyl)-sulphone (DDS) (Burroughs Wellcome Co., 
Bombay) at a concentration of 1 µg/Leighton tube (1 µg/0·7 ml of medium) or 
rifampicin (Sigma Chemicals Co., St. Louis, Missouri, USA) (10 µg/ml) for 72 h before 
M. leprae were added. Some of the control macrophages were not infected with M. 
leprae and used to study the effect of the drug alone and cholesterol uptake on lipid 
synthesis. In the drug treated cultures after 24 h of phagocytosis excess bacilli was 
washed off and the macrophages were labelled with [3H]-cholesterol/[14C]-acetate
and left for 4 days for studying the uptake and synthesis of the lipids in the presence of 
the drug. 
[3H]-Cholesterol was obtained as crude tritiated product from Bhabha Atomic 
Research Centre, Bombay and purified by repeated thin layer chromatography and 
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0·16 µ Ci was used for the uptake studies in each Leighton tube. [14C]-Acetate (with sp. 
activity of 56·7 µCi/m mol from Bhabha Atomic Research Centre, Bombay) was added 
in each Leighton tube at a level of 0·5 µCi. Many of the other parameters have been 
optimised during our earlier work, that has been reported (Iswari Kurup and 
Mahadevan 1982). 
 
 
Extraction and separation of lipids 
 
Following incubation, the macrophages were scrapped off the surface of the glass, the 
cells were microscopically counted and the lipids were extracted according to Dole’s 
method (Dole, 1956). Lipids were separated by thin-layer chromatography on 20 
× 20 cm plates coated with silica gel (Chemical division, Glaxo laboratory, Bombay), at 
room temperature using hexane: ether:acetic acid (80:20:1) as development solvent. 
Identification of the lipid spots was made by staining with iodine vapours, using for 
reference, standard lipids (Sigma Chemicals Co., St. Louis, Missouri, USA). 
 
Determination of incorporation into lipids 
 
After identification of the lipid spots, the silica gel corresponding to the position of each 
standard, from the experimental sample, was carefully scrapped into scintillation vials. 
This was done after the evaporation of iodine and full decolourization. Bray’s 
scintillation fluid (10 ml) was added to each vial and its radioactivity determined by 
using Kontron MR-300 automatic scintillation counter. 
Since each experiment is done with separate crop of macrophages from mice and 
bacteria derived from different patient materials, variability is a problem. This has been 
partially overcome with averaging the experimental values with indication of standard 
deviation and P values. 
 
 
Results 
 
We had shown earlier that macrophages with or without M. leprae were able to 
incorporate [14C]-acetate into lipids and also take up cholesterol and convert a portion 
of it to cholesterol ester (Ishwari Kurup and Mahadevan, 1982). 
When labelled cholesterol was used for uptake studies it was observed that the total 
uptake of cholesterol inside the macrophages was comparatively less when they were 
infected with M. leprae. Nevertheless, presence of M. leprae, induced increased level of 
cholesterol ester as seen by the higher ratio of labelled cholesterol ester to cholesterol in 
the culture, as compared with macrophages with no M. leprae (table 1). No such 
increase in the ester level was seen in macrophages exposed to autoclaved M. leprae 
(table 1). But if the macrophages had been exposed to the drug earlier and then M. 
leprae were added and the bacteria were exposed to such intracellular drug for 24 h 
before the cholesterol uptake during the next 4 days, then the results would be as shown 
in table 1. This showed that DDS was able to inactivate M. leprae from both armadillo 
as well as those derived from human leproma tissues. Due to this inactivation the 
cholesterol ester level was not increased and the ratio of cholesterol ester to cholesterol 
(as radioactivity associated with ester to that associated with cholesterol) was 
6
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statistically similar to the control and/or heat killed M. leprae added macrophages. 
There was a lower level of cholesterol in macrophages, in live M. leprae added cultures 
as compared with others. This could be due to a decreased uptake of cholesterol since 
label is added after M. leprae addition or due to conversion of cholesterol to some other 
components, besides the ester. This is a noteworthy feature for future studies. 
Table 2 presents data from a typical experiment using [14C]-acetate as a precursor to 
determine the level of cholesterol ester in the macrophages. Results are similar as seen in 
table 1, indicating the sensitivity of M. leprae to the drug DDS. The consolidated data 
of 9 such experiments are presented in table 3 and the statistically significant difference 
 
Table 2. Incorporation of [14C]-acetate into cholesterol and cholesterol ester in macro-
phages (cpm/106 macrophages) with and without human M. leprae and drug (biopsy No. 483).
 
 
* Dapsone (DDS). 
** Ratio of radioactivity (cpm) in cholesterol ester to that in cholesterol/106 macrophages.
 
Table 3. Ratio of cholesterol ester/cholesterol during different treatments with different
preparation of M. leprae (ratio of radioactivity (cpm) in cholesterol ester to that in
cholesterol/106 macrophages). 
 
 
  * Using labelled cholesterol. 
** Using labelled [14C]-acetate. 
a – b  P – (n.s.) 
c – a   P < 0.025 
c – b   P – (n.s.) 
e – a  P – (n.s.) 
d – e  P value > 0.5 (n.s.) 
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(by student ‘t’ test) of the cholesterol ester level in macrophage containing live M. leprae 
and drug treated M. leprae is clear. It is noteworthy that the human biopsy derived M. 
leprae were from six different patients and the three armadillo derived M. leprae are 
from one infected tissue of armadillo. The value of ratio for each of the experimental 
conditions varied from experiment to experiment probably due to variability in the 
macrophage population. So a larger number of experiments will be needed in fully 
standardised conditions to narrow the difference and also do an analysis of variance. 
However, the same population of macrophage has consistent behaviour, as expected by 
the condition of experimentation. Thus, the data on the ratio is represented as an 
average of all experiments with the standard deviation under each category and P values 
determined for these average values for each comparable categories. 
One basic requirement in any method that indicates the viability of M. leprae is that 
the parameter tested should vary with difference in the viability of the test bacterium. 
We could clearly demonstrate this using varying levels of M. leprae with constant 
amount of macrophages (table 4). This showed that, as viable M. leprae increased, the 
level of cholesterol ester was also augmented with increasing level of the ratio of 
cholesterol to its ester. This indicated that the phenomenon depended on the presence of 
viable bacteria and thus would reflect the viability of the test M. leprae as well. No linear 
relationship is seen, because, there could not be an uniform ratio of live to dead M. 
leprae in all aliquots, since M. leprae basically came from human tissues. 
 
Table 4. Effect of increasing amount of M. leprae in the cholesterol 
metabolism of macrophages (ratio of radioactivity (cpm) in cholesterol 
ester to that in cholesterol/106 macrophages). 
 
 
Recently the concentration of DDS within 106 macrophages when the cells were 
exposed to 1 µg of DDS has been determined by Jagannathan and Mahadevan 
(personal communication). It is estimated as 25ng/106 macrophages and each 
macrophage is expected to have DDS to a level of 1·7–12·5 µg/ml. The estimation was 
done by them using fluorometric measurement which has a sensitivity upto 4 ng level of 
DDS. The concentration obtained in the macrophages is much higher than the 
minimum inhibition concentration 0·003 µg/ml needed to function as bacteriostatic to 
M. leprae as reported by Ellard et al. (1971) and Peters et al. (1975). 
Experiments were also done using M. leprae derived from clinically relapsed patients 
and those suspected to harbour drug resistant bacteria in their bodies. In such 
experiments it was clear that M. leprae showed no sensitivity to the drug, dapsone, since 
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even in the presence of dapsone inside the macrophages, they behaved as if they were
alive, by increasing the cholesterol ester level more than the control. The data in table 5 
presents one such isolate (biopsy No. 499 using [14C]-acetate as labelled precursors) 
and table 6 presents a consolidated data on all the five separately isolated bacteria. 
 
 
Table 5. Cholesterol and the ester level in macrophages exposed to 
“resistant” bacilli isolated from clinically relapsed patient during 
dapsone (DDS) treatment (cpm/106 macrophages). 
 
 
*Ratio of radioactivity (cpm) is cholesterol ester to that in cholesterol/106 
macrophages. 
 
 
Table 6. Ratio of cholesterol ester/cholesterol in macrophages exposed “resistant” bacteria
during different conditions (ratio of radioactivity (cpm) in cholesterol ester to that in
cholesterol/106 macrophages). 
 
 
  * Using labelled cholesterol. 
** Using labelled acetate. 
a – e; P < 0·025 
c – e; P < 0·05 
(no. of experiments = 5). 
 
 
Similar results were obtained with another drug rifampicin and with [14C]-acetate as
precursors as shown in table 7 and it could be seen that of the 3 isolates tested all the 3 
were sensitive to rifampicin. 
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Confirmation by mouse foot-pad 
 
Since the mouse foot-pad test is generally accepted as a reliable procedure for viability 
(Shepard, 1960, 1967) we confirmed the drug sensitivity/resistance of some isolates 
from the human biopsies by both mouse foot-pad method and the method described in 
this paper. Such isolates are FMR 423,435,277. The mouse foot-pad tests were carried 
out as per the procedures of Rees (1964) and Shepard (1967). All the three isolates tested 
and shown to be resistant to dapsone by the cholesterol uptake method were found to 
be resistant to the drug by growing in mice fed with varying concentration of the drug 
(tables 8 and 9). 
 
 
Table 8. Correlation of resistance of M. leprae to drug (dapsone) by the in vitro 
method and mouse foot-pad experiment. 
 
 
 
 
Table 9. Mouse foot-pad growth of M. leprae from patient biopsy FMR 435 
suspected to have drug resistant M. leprae. 
 
 
BI–Bacteriological index–total bacterial load. 
MI–Morphological index–viable bacteria load. 
AFB/FP–Acid fast bacilli per foot-pad. 
* Mice fed with indicated concentration of DDS. 
PP–Foot-pad. 
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Discussion 
 
It is clear from our earlier data (Ishwari Kurup and Mahadevan, 1982) and from the 
present experiments that heat killed M. leprae have no ability to interact with 
macrophages of mice to allow increased accumulation of cholesterol ester. Using this 
information the viability of M. leprae in the presence of drug inside the macrophages 
could be assessed. This has been possible to do so, as illustrated from the data provided 
in tables 1 and 6 when DDS and rifampicin, respectively, were used as the drugs. 
Viability or otherwise in the presence of drug would be indicated by cholesterol ester 
accumulation and this in turn would indicate sensitivity/resistance of the M. leprae to 
the drug tested. This method is reliable and consistent as has also been shown by 
correlative information of the drug sensitivity resistance of the same M. leprae 
preparation as tested by mouse foot-pad technique. 
A few other in vitro techniques have been described using uptake of radioactive
dihydroxyphenylalanine (DOPA) by M. leprae as an indicator of viability (Ambrose et 
al., 1978); incorporation of [3H]-thymidine by M. leprae, phagocytosed inside 
macrophages (Nath et al., 1982 and Prasad et al., 1981) or incorporation of [14C]-acetate 
into lipids of M. leprae while the bacteria are still in isolated human tissues (Lakshmi et 
al., 1983). All these have been used with reasonable success for screening the viability 
and drug sensitivity of M. leprae from human biopsies. A major problem that has to be 
overcome with M. leprae is their inability to grow in vitro in any bacteriological 
medium in a short time. Thus one has to use some metabolic activity as an indicator of 
the non dividing bacteria for viability testing. 
The advantages of the drug screening system described here is that it can use
macrophages derived from mice and the readily available labelled compound [14C]- 
acetate. The test can be completed in 9 days time and the results are consistent 
thus far. Since metabolic compounds are isolated and the radioactivity (at appreciable 
levels) are estimated in these compounds, so greater confidence exists. By a clear 
demonstration of a metabolic trigger in the host cell by the live bacteria, we are able to 
assay the viability of non-dividing M. leprae in the in vitro system which is probably 
closer to what happened in an in vivo situation. As indicated in our earlier paper 
cholesterol ester accumulation has a significance to the foamy nature of host cells 
infected with M. leprae. Thus the process monitored is one that could be occurring in 
the pathological state of leprosy in the patient. These advantages clearly put this 
technique, perhaps, above all the other methods described so far. 
Experiments for further standardization of the technique and adoption of the
method to determine minimum inhibition concentration of the known drugs are in
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